G1A Stock Analysis: GEA | XETRA
Specialty Industrial Machinery | XETRA, Germany | Market Cap: 10.533m EUR | 12M Return: 4.6% | DE0006602006 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 20.2M
EPS Trend: 49.7%
Qual. Beats: 0
Rev. Trend: 84.7%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
GEA Group Aktiengesellschaft is a German industrial machinery manufacturer headquartered in Düsseldorf that produces process equipment and components for the food, beverage, and pharmaceutical industries worldwide. The company operates through five segments: Separation & Flow Technologies; Liquid & Power Technologies; Food & Health Technologies; Farm Technologies; and Heating & Refrigeration Technologies, allowing it to serve customers across the full production value chain rather than just one niche.
Its product portfolio includes core process components such as separators, decanters, homogenizers, valves, and pumps, as well as integrated processing lines for brewing, fermentation, drying, packaging, and pharmaceutical manufacturing (including tablet presses and granulators). The dairy processing equipment business is a particularly established niche, while newer offerings extend to carbon capture systems, emission control, vegan and alternative-protein processing, and digital herd management for livestock farms.
GEAs business model combines large capital equipment sales with recurring revenue from spare parts, maintenance, and digital services, which is typical for industrial machinery vendors and tends to provide more stable cash flow than new-equipment sales alone. Founded in 1881 and originally known as mg technologies ag, the company adopted its current name in 2005.
- Service revenue expansion supports margin growth
- Pharma processing equipment orders accelerate on tablet press demand
- Dairy and food capital expenditure drives Separation segment backlog
| Net Income: 434.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.17 > 1.0 |
| NWC/Revenue: 2.88% < 20% (prev 1.05%; Δ 1.83% < -1%) |
| CFO/TA 0.12 > 3% & CFO 723.1m > Net Income 434.1m |
| Net Debt (240.5m) to EBITDA (913.0m): 0.26 < 3 |
| Current Ratio: 1.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (162.8m) vs 12m ago 0.0% < -2% |
| Gross Margin: 37.50% > 18% (prev 36.82%; Δ 0.67% > 0.5%) |
| Asset Turnover: 96.40% > 50% (prev 96.50%; Δ -0.10% > 0%) |
| Interest Coverage Ratio: 14.83 > 6 (EBIT TTM 680.7m / Interest Expense TTM 45.9m) |
| A: 0.03 (Total Current Assets 2.72b - Total Current Liabilities 2.56b) / Total Assets 6.08b |
| B: 0.13 (Retained Earnings 792.9m / Total Assets 6.08b) |
| C: 0.12 (EBIT TTM 680.7m / Avg Total Assets 5.85b) |
| D: 0.70 (Book Value of Equity 2.50b / Total Liabilities 3.58b) |
| Altman-Z'' = 2.12 = BBB |
| DSRI: 1.17 (Receivables 1.27b/1.04b, Revenue 5.64b/5.43b) |
| GMI: 0.98 (GM 36.82% / 37.50%) |
| AQI: 0.96 (AQ_t 0.39 / AQ_t-1 0.40) |
| SGI: 1.04 (Revenue 5.64b / 5.43b) |
| TATA: -0.05 (NI 434.1m - CFO 723.1m) / TA 6.08b) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of August 24, 2026, the stock is trading at EUR 65.80 with a total of 261,304 shares traded. Over the past week, the price has changed by +1.39%, over one month by +3.95%, over three months by +18.56% and over the past year by +4.55%.
Current recommended Stop Loss: 64.30 (which is 2.3% or 1.4 ATR below the current price).
GEA has no consensus analysts rating.
P/E Trailing = 24.1418
P/E Forward = 18.0505
P/S = 1.8668
P/B = 4.2089
P/EG = 1.0872
Revenue TTM = 5.64b EUR
EBIT TTM = 680.7m EUR
EBITDA TTM = 913.0m EUR
Long Term Debt = 143k EUR (from longTermDebt, last fiscal year)
Short Term Debt = 122.7m EUR (from shortTermDebt, last quarter)
Debt = 573.6m EUR (from shortLongTermDebtTotal, last quarter) + Leases 246.4m
Net Debt = 240.5m EUR (calculated: Debt 573.6m - CCE 333.2m)
Enterprise Value = 10.8b EUR (10.5b + Debt 573.6m - CCE 333.2m)
Interest Coverage Ratio = 14.83 (Ebit TTM 680.7m / Interest Expense TTM 45.9m)
EV/FCF = 22.12x (Enterprise Value 10.8b / FCF TTM 487.0m)
FCF Yield = 4.52% (FCF TTM 487.0m / Enterprise Value 10.8b)
FCF Margin = 8.63% (FCF TTM 487.0m / Revenue TTM 5.64b)
Net Margin = 7.70% (Net Income TTM 434.1m / Revenue TTM 5.64b)
Gross Margin = 37.50% ((Revenue TTM 5.64b - Cost of Revenue TTM 3.53b) / Revenue TTM)
Gross Margin QoQ = 38.64% (prev 38.06%)
Tobins Q-Ratio = 1.77 (Enterprise Value 10.8b / Total Assets 6.08b)
Interest Expense / Debt = 8.00% (Interest Expense 45.9m / Debt 573.6m)
Taxrate = 31.30% (199.1m / 636.0m)
NOPAT = 467.6m (EBIT 680.7m * (1 - 31.30%))
Current Ratio = 1.06 (Total Current Assets 2.72b / Total Current Liabilities 2.56b)
Debt / Equity = 0.23 (Debt 573.6m / totalStockholderEquity, last quarter 2.50b)
Debt / EBITDA = 0.26 (Net Debt 240.5m / EBITDA 913.0m)
Debt / FCF = 0.49 (Net Debt 240.5m / FCF TTM 487.0m)
Total Stockholder Equity = 2.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.42% (Net Income 434.1m / Total Assets 6.08b)
RoE = 17.54% (Net Income TTM 434.1m / Total Stockholder Equity 2.48b)
RoCE = 27.50% (EBIT 680.7m / Capital Employed (Equity 2.48b + L.T.Debt 143k))
RoIC = 13.93% (NOPAT 467.6m / Invested Capital 3.36b)
WACC = 6.61% (E(10.5b)/V(11.1b) * Re(6.67%) + D(573.6m)/V(11.1b) * Rd(8.00%) * (1-Tc(0.31)))
Discount Rate = 6.67% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -89.99 | Cagr: -1.88%
[DCF] Terminal Value 76.71% ; FCFF base≈468.7m ; Y1≈511.1m ; Y5≈638.4m
[DCF] Fair Price = 58.51 (EV 9.77b - Net Debt 240.5m = Equity 9.53b / Shares 162.8m; r=8.35% [WACC [floored]]; 5y FCF grow 10.40% → 2.50% )
EPS Correlation: 49.66 | EPS CAGR: 1.91% | SUE: -0.58 | # QB: 0
Revenue Correlation: 84.75 | Revenue CAGR: 1.58% | SUE: 1.53 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.85 | Chg30d=+4.28% | Revisions=+25% | Analysts=2
EPS current Year (2026-12-31): EPS=3.39 | Chg30d=+2.99% | Revisions=+55% | GrowthEPS=+23.6% | GrowthRev=+6.9%
EPS next Year (2027-12-31): EPS=3.76 | Chg30d=+4.46% | Revisions=+73% | GrowthEPS=+11.1% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: +75% (up=16, down=1)